New York § 2024 Duties of the commissioner

New York Statutes

§ 2024 — Duties of the commissioner

New York § 2024

Law PBHPublic Health

Art. 20-C*2State Amyotrophic Lateral Sclerosis and Motor Neuron Disease Registry

This text of New York § 2024 (Duties of the commissioner) is published on Counsel Stack Legal Research, covering New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

N.Y. Public Health § 2024 (2026).

Text

  § 2024. Duties of the commissioner. The commissioner may promulgate\nany regulations necessary to implement the provisions of this article,\nincluding but not limited to:\n  1. Establishing the form, content, and manner by which providers shall\nreport ALS and MND information into the registry established under\nsection two thousand twenty-two of this article;\n  2. Prescribing the permissible uses for the information made available\nunder this article; and\n  3. Establishing procedures to maintain confidentiality of information\ncollected by providers and provided to members of the department\npursuant to this article. This shall include a procedure to ensure that\nconfidential patient information is deidentified prior to being provided\nto authorized participants under this article.\n

Free access — add to your briefcase to read the full text and ask questions with AI

§ 2024. Duties of the commissioner. The commissioner may promulgate\nany regulations necessary to implement the provisions of this article,\nincluding but not limited to:\n 1. Establishing the form, content, and manner by which providers shall\nreport ALS and MND information into the registry established under\nsection two thousand twenty-two of this article;\n 2. Prescribing the permissible uses for the information made available\nunder this article; and\n 3. Establishing procedures to maintain confidentiality of information\ncollected by providers and provided to members of the department\npursuant to this article. This shall include a procedure to ensure that\nconfidential patient information is deidentified prior to being provided\nto authorized participants under this article.\n